{"gene":"METTL16","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2017,"finding":"METTL16 is the N6-methyladenosine (m6A) methyltransferase responsible for methylating the U6 spliceosomal snRNA, and it regulates MAT2A (SAM synthetase) expression by methylating a conserved hairpin (hp1) in the MAT2A 3' UTR. Under SAM-limiting conditions, increased METTL16 occupancy on hp1 due to inefficient enzymatic turnover promotes splicing of a retained intron in MAT2A pre-mRNA, thereby inducing MAT2A expression to restore SAM homeostasis.","method":"In vitro methylation assays with recombinant METTL16, siRNA knockdown, intron retention/splicing assays, methionine starvation experiments, mutational analysis of hairpin substrates","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (in vitro assays, mutagenesis, cellular knockdown, splicing assays) in a rigorous study; independently replicated by subsequent papers","pmids":["28525753"],"is_preprint":false},{"year":2017,"finding":"METTL16 is responsible for N6-methylation of A43 of the U6 snRNA and interacts with early U6 biogenesis factors La, LARP7, and the methylphosphate capping enzyme MEPCE. A43 lies within the ACAGAGA box of U6 that base-pairs with 5' splice sites during splicing, implicating this modification in splicing regulation.","method":"CRAC (crosslinking and analysis of cDNA), in vivo methylation assays, co-immunoprecipitation identifying La, LARP7, MEPCE as interaction partners","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRAC mapping plus co-IP of interaction partners, replicated across multiple labs confirming U6 A43 methylation","pmids":["29051200"],"is_preprint":false},{"year":2017,"finding":"METTL16-mediated m6A modification of the MAT2A 3' UTR is read by the m6A reader YTHDC1, and this METTL16-YTHDC1 axis controls SAM-responsive regulation of MAT2A mRNA stability. In vitro reactions with recombinant METTL16 identified multiple conserved methylation targets in the MAT2A 3' UTR, and mutations of these adenine sites revealed redundancy in regulation.","method":"In vitro methylation assays with recombinant METTL16, siRNA knockdown of METTL16 and YTHDC1, mutagenesis of m6A target sites, mRNA stability assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro reconstitution with recombinant protein, mutagenesis, and cellular knockdown in single lab with multiple orthogonal methods","pmids":["29262316"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of human METTL16 reveals a methyltransferase domain with an extra N-terminal module forming a deep-cut groove essential for RNA binding, showing it selects for structured RNAs where the critical adenosine is present in a bulge. Mouse embryos lacking Mettl16 show reduced Mat2a mRNA levels, massive transcriptome dysregulation at the ~64-cell blastocyst stage, and failure of further development.","method":"X-ray crystallography, Mettl16 knockout mouse embryo analysis, RNA-seq of knockout embryos","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation and in vivo knockout phenotype, multiple orthogonal methods","pmids":["30197299"],"is_preprint":false},{"year":2018,"finding":"Crystal structures of METTL16 in complex with MAT2A RNA hairpins reveal atomic details of RNA substrate recognition for productive methylation. A polypeptide loop near the SAM binding site has an autoregulatory role; mutations that enhance or repress METTL16 activity in vitro correlate with changes in MAT2A mRNA levels in cells.","method":"X-ray crystallography of METTL16-RNA complexes, in vitro methylation assays, mutagenesis correlated with cellular MAT2A levels","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures with mutagenesis and in vitro/cellular validation in a single rigorous study","pmids":["30197297"],"is_preprint":false},{"year":2018,"finding":"X-ray crystal structures of the METTL16 N-terminal methyltransferase domain (residues 1-291) in apo form and SAH-bound complex reveal a Rossmann fold with a large positively charged groove as the RNA-binding site. Full-length METTL16 forms a homodimer and METTL16_291 is a monomer; the full-length protein but not the monomeric domain binds the MALAT1 RNA triple helix. The catalytic mechanism involves Class I SAM-dependent methyltransferase chemistry.","method":"X-ray crystallography (1.9 Å apo; 2.1 Å SAH complex), size-exclusion chromatography, native gel-shift assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures with biochemical validation (SEC, gel-shift), single lab with multiple orthogonal structural and biochemical methods","pmids":["29593291"],"is_preprint":false},{"year":2020,"finding":"The vertebrate conserved region (VCR) of METTL16 increases affinity toward U6 snRNA via a conserved basic region, and is topologically homologous to the KA1 domain of TUT1. The VCR interacts with the internal stem-loop (ISL) of U6 snRNA, inducing conformational rearrangement of the A43-containing region to make it suitable for productive catalysis by the methyltransferase domain (MTD). A chimera of METTL16 MTD with TUT1 KA1 methylated U6 snRNA more efficiently than MTD alone.","method":"Structural analysis, RNA binding assays, chimeric protein construction and methylation assays, mutational analysis of VCR basic region","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — structural and functional analyses combined with chimeric protein reconstitution and mutagenesis in a single thorough study","pmids":["32266935"],"is_preprint":false},{"year":2020,"finding":"Biochemical fractionation reveals that a majority of METTL16 protein resides in the cytoplasm in multiple cell lines, in addition to the nucleus, suggesting METTL16 functions as a cytoplasmic RNA binding protein. Exogenously overexpressed METTL16 differs from endogenous protein in its relative affinity for RNA targets.","method":"Biochemical cell fractionation, immunoprecipitation of endogenous and FLAG-tagged METTL16, siRNA knockdown with mRNA target expression analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 / Weak — biochemical fractionation in single lab; single method for localization without full functional consequence established","pmids":["31940410"],"is_preprint":false},{"year":2021,"finding":"METTL16 nuclear distribution is cell cycle-specific: it accumulates in the nucleolus in G1/S phases, increases in the nucleoplasm in G2, is very low in metaphase/anaphase, and reappears at the nuclear lamina in telophase. METTL16 interacts with Lamin B Receptor (LBR) and Lap2α (but not A- or B-type lamins), with Lap2α depletion causing METTL16 downregulation. METTL16 also interacts with DDB2 (NER factor) and nucleolar proteins TCOF, NOLC1, and UBF1/2.","method":"Live cell imaging and immunofluorescence for cell cycle stages, co-immunoprecipitation for protein interactions, A-type lamin depletion experiments","journal":"Life (Basel, Switzerland)","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — cell cycle-resolved localization by imaging plus Co-IP for multiple interaction partners, single lab","pmids":["34357041"],"is_preprint":false},{"year":2022,"finding":"METTL16 exerts an m6A-independent function in the cytosol by directly interacting with eukaryotic initiation factors eIF3a and eIF3b as well as ribosomal RNA through its methyltransferase domain, thereby facilitating assembly of the translation-initiation complex and promoting translation of >4,000 mRNA transcripts. In the nucleus, METTL16 additionally functions as an m6A writer on hundreds of specific mRNA targets.","method":"Co-immunoprecipitation of eIF3a/eIF3b, ribosome profiling, m6A-seq, methyltransferase-dead mutant complementation, dual nuclear/cytoplasmic localization experiments","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP plus ribosome profiling and mutant complementation; single lab but multiple orthogonal methods","pmids":["35145225"],"is_preprint":false},{"year":2022,"finding":"METTL16 interacts with MRE11 through RNA (in a methyltransferase-independent manner) and this interaction inhibits MRE11's exonuclease activity, thereby repressing DNA end resection. Upon DNA damage, ATM phosphorylates METTL16, causing a conformational change and autoinhibition of its RNA binding, which dissociates the METTL16-RNA-MRE11 complex and releases MRE11 to promote homologous recombination repair.","method":"Co-immunoprecipitation, in vitro exonuclease assays with recombinant proteins, ATM kinase assays, phosphomimetic/phospho-dead mutants, RNA-dependent interaction assays","journal":"Nature cancer","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — in vitro exonuclease reconstitution, Co-IP, mutagenesis of phosphorylation sites, multiple orthogonal methods in single study","pmids":["36138131"],"is_preprint":false},{"year":2022,"finding":"METTL16 promotes translation and lung tumorigenesis through an m6A-independent mechanism: cytoplasmic METTL16 directly interacts with eIF4E2, preventing eIF4E2 from competing with eIF4E for 5' cap binding, thereby promoting cap recognition by eIF4E and selective protein synthesis of key oncogenes.","method":"Co-immunoprecipitation of eIF4E2, cap-binding assays, methyltransferase-dead mutant analysis, siRNA depletion with polysome profiling, dual localization confirmed","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus functional assays with mutants, single lab; complements but partially overlaps with Su et al. 2022 finding on translation","pmids":["36840945"],"is_preprint":false},{"year":2022,"finding":"METTL16 promotes expression of BCAT1 and BCAT2 in an m6A-dependent manner, reprogramming branched-chain amino acid (BCAA) metabolism to support AML leukemogenesis and leukemia stem cell self-renewal.","method":"CRISPR-Cas9 screening, genetic depletion in AML mouse models, m6A-seq, RIP-seq, metabolic profiling of BCAA metabolism","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR screen validated by genetic depletion in vivo, m6A-seq, and metabolic readouts; single lab with multiple orthogonal methods","pmids":["36608679"],"is_preprint":false},{"year":2022,"finding":"METTL16 is lactylated at site K229, a modification inhibited by SIRT2. Copper stress promotes METTL16 lactylation, which enhances METTL16-mediated m6A modification of FDX1 mRNA, promoting cuproptosis in gastric cancer.","method":"Mass spectrometry identification of lactylation sites, SIRT2 inhibition/overexpression, MeRIP for FDX1 m6A, in vitro and in vivo cuproptosis assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — MS identification of PTM site plus functional validation with writer/eraser (SIRT2) and downstream m6A target; multiple orthogonal methods in single study","pmids":["37863889"],"is_preprint":false},{"year":2022,"finding":"METTL16 negatively regulates MCP1 expression in mesenchymal stem cells through m6A modification of MCP1 mRNA at the CDS region, which is recognized by the m6A reader YTHDF2 to promote MCP1 mRNA degradation, thereby controlling monocyte recruitment.","method":"siRNA knockdown, MeRIP (m6A-RIP), RIP for YTHDF2, mRNA stability assays, in vivo monocyte recruitment assay","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — MeRIP plus RIP and stability assays, identified specific CDS m6A sites; single lab","pmids":["36795489"],"is_preprint":false},{"year":2022,"finding":"METTL16 is required for proper erythropoiesis by safeguarding genome integrity via m6A deposition on structured motifs in DNA-repair-related transcripts including Brca2 and Fancm mRNAs, upregulating their expression. A pairwise CRISPRi screen revealed that the MTR4-nuclear RNA exosome complex is involved in regulating METTL16 substrate mRNAs in erythroblasts.","method":"METTL16 conditional knockout in erythroid cells, m6A-seq, RNA-seq, pairwise CRISPRi screens, DNA damage markers","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined molecular phenotype, m6A-seq, genetic epistasis via CRISPRi screen; single lab with multiple orthogonal methods","pmids":["36307435"],"is_preprint":false},{"year":2022,"finding":"METTL16 kinetic mechanism is ordered-sequential: METTL16 binds U6 snRNA before SAM. METTL16 is monomeric when in complex with MALAT1 triple helix or U6 snRNA, with dissociation constants of 31 nM (MALAT1) and 18 nM (U6 snRNA). The MALAT1 triple helix is not methylated by METTL16 under in vitro conditions. The kcat is 0.07 min-1 and kchem is 0.56 min-1; the VCR domains weaken the ternary complex but do not limit the rate of chemical catalysis.","method":"In vitro binding assays (Kd measurements), preincubation and isotope partitioning assays, steady-state and single-turnover kinetic assays","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — rigorous in vitro kinetic reconstitution with multiple complementary assay types establishing ordered mechanism; single lab","pmids":["36584291"],"is_preprint":false},{"year":2023,"finding":"METTL16 methylation consensus sequence is UACAGARAA (modified A underlined), and structural requirements exist for its known RNA interactors; the methyltransferase domain contains a Rossmann-like fold characteristic of class I SAM-dependent methyltransferases and uses SAM as the methyl donor.","method":"Review synthesizing structural and biochemical data (not primary experimental data in this paper)","journal":"Wiley interdisciplinary reviews. RNA","confidence":"Medium","confidence_rationale":"Tier 3 / Strong — review consolidating replicated experimental findings from multiple primary studies","pmids":["34227247"],"is_preprint":false},{"year":2023,"finding":"Inter-species association mapping links 5' splice site sequence preferences (particularly the +4 position adenosine vs. uridine preference) to the presence of METTL16 and SNRNP27K. Loss of METTL16 orthologs is associated with a preference for +4 U at 5' splice sites, consistent with the role of METTL16-mediated U6 snRNA m6A in splice site recognition.","method":"Inter-species association mapping across Saccharomycotina species, genetic analysis of METTL16/SNRNP27K mutants, splice site sequence analysis","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cross-species genetic epistasis/association mapping with mutant validation; novel approach providing orthogonal evidence for U6 m6A function in splicing","pmids":["37787376"],"is_preprint":false},{"year":2024,"finding":"METTL16 controls ribosomal RNA (rRNA) maturation and mRNA translation, and eIF3a mRNA is a bona fide m6A target of METTL16 in HCC. METTL16 depletion dramatically decreases liver cancer stem cell frequency in vitro and in vivo, and attenuates HCC initiation/progression in liver-specific knockout mice.","method":"Liver-specific conditional knockout mice, hydrodynamic tail-vein injection HCC model, RNA-seq, RIP-seq, ribosome profiling, limiting dilution assay, CRISPR tiling scan","journal":"Journal of hematology & oncology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO mice with multiple in vivo models, ribosome profiling, RIP-seq identifying eIF3a as direct target; single lab with multiple orthogonal methods","pmids":["38302992"],"is_preprint":false},{"year":2024,"finding":"METTL16 regulates alternative splicing of meiosis-related genes (e.g., Stag3) by interacting with splicing factors, and controls translation efficiency of meiotic genes; germline conditional knockout of Mettl16 in male mice impairs spermatogonial differentiation and meiosis initiation. The methyltransferase activity site (PP185-186AA) is necessary for spermatogenesis.","method":"Germline conditional knockout mice, m6A-seq, RNA-seq, ribosome profiling, in vivo/vitro methyltransferase mutant complementation, co-IP with splicing factors","journal":"Genome biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with multiple omics (m6A-seq, ribosome profiling) and mutagenesis validation; single lab with orthogonal methods","pmids":["39030605"],"is_preprint":false},{"year":2024,"finding":"METTL16 controls cell cycle progression of embryonic hematopoietic stem and progenitor cells by directly regulating mybl2b mRNA via m6A modification. Mettl16 deficiency destabilizes mybl2b mRNA, likely due to lost binding by the m6A reader Igf2bp1, causing G1/S cell cycle arrest. This METTL16-m6A-MYBL2-IGF2BP1 axis is conserved in humans.","method":"Mettl16-deficient zebrafish, single-cell RNA-seq, m6A-seq, RIP for Igf2bp1, cell cycle analysis, methyltransferase-activity mutant rescue experiments","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — zebrafish KO with m6A-seq, RIP, and activity-mutant rescue; cross-species conservation validated; single lab with multiple orthogonal methods","pmids":["38605226"],"is_preprint":false},{"year":2024,"finding":"METTL16 is required for meiotic sex chromosome inactivation (MSCI), DSB formation, homologous recombination, and SYCP1 deposition during male meiosis. METTL16 interacts with MDC1/SCML2 to coordinate DNA damage response and XY body epigenetic modifications establishing MSCI; it also regulates m6A levels and translational efficiency of meiosis-related genes including Ubr2.","method":"METTL16 spermatocyte-specific knockout mice, multi-omics (m6A-seq, RNA-seq, ribosome profiling, proteomics), Co-IP with MDC1/SCML2","journal":"Advanced science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with multi-omics and Co-IP of mechanistic partners; single lab with multiple orthogonal methods","pmids":["39607422"],"is_preprint":false},{"year":2024,"finding":"METTL16 and its reader YTHDC1 are required for spermatogonial differentiation; deletion of Mettl16 using Stra8-Cre causes blockade in spermatogonial differentiation and progressive loss of spermatogonia. RNA-seq and m6A-seq showed that loss of either METTL16 or YTHDC1 disrupts expression of genes related to chromosome organisation and segregation.","method":"Conditional knockout mice (Mettl16vasa-cre, Mettl16Stra8-cre, Ythdc1-sKO), RNA-seq, m6A-seq","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with omics; partial mechanistic follow-up; single lab","pmids":["39614650"],"is_preprint":false},{"year":2024,"finding":"CDK13 directly phosphorylates METTL16 at Ser329, augmenting its catalytic activity to install m6A on ACLY mRNA. These m6A marks are recognized by YTHDC2, leading to ACLY mRNA stabilization, increased acetyl-CoA production, and lipogenesis in clear cell renal cell carcinoma.","method":"In vitro kinase assay (CDK13 phosphorylating METTL16), phosphomimetic/phospho-dead METTL16 mutants, MeRIP for ACLY m6A, RIP for YTHDC2, mRNA stability assays","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay plus mutagenesis and MeRIP in single lab; single study identifying PTM writer","pmids":["41680470"],"is_preprint":false},{"year":2024,"finding":"SSB functions as a cofactor for METTL16 in installing m6A RNA methylation by enhancing METTL16 binding to RNA. SSB is itself a direct target of METTL16-mediated m6A RNA methylation, forming a positive auto-regulatory loop promoting m6A methylation, SSB expression, and chemoresistance.","method":"Co-immunoprecipitation, RNA binding assays, MeRIP for SSB mRNA, siRNA knockdown, chemoresistance assays","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP and MeRIP establishing SSB as cofactor and substrate; single lab; auto-regulatory loop supported by multiple methods","pmids":["40580478"],"is_preprint":false},{"year":2025,"finding":"The catalytic efficiency of METTL16 governs the intracellular SAM setpoint: catalytically hyperactive METTL16 complements methyltransferase activities but decreases intracellular SAM concentrations by abrogating MAT2A regulation, making cells hypersensitive to MAT2A inhibition and MTAP deletion. U6 snRNA pseudogenes are identified as additional METTL16 substrates.","method":"Degron-based depletion and complementation strategy in HCT116 cells, hyperactive/catalytically-dead mutant METTL16 constructs, intracellular SAM measurement, histone methylation and RNA methylation assays, MTAP gene deletion","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — rigorous degron/complementation with mutant panel and metabolic readouts; demonstrates catalytic efficiency as direct regulator of SAM setpoint; single lab with multiple orthogonal methods","pmids":["40644296"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structures of METTL16 in complex with U6 snRNA reveal that the C-terminal KA-1 domain recruits U6 snRNA by interacting with the internal stem-loop (ISL). SAM binding to the N-terminal MTD catalytic pocket triggers a structural rearrangement of U6 snRNA that positions the target adenine at the catalytic site, followed by an additional adjustment into a productive conformation bringing the target adenosine closer to SAM for efficient m6A modification.","method":"Cryo-EM structure determination of METTL16-U6 snRNA complex","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure providing atomic-level mechanistic insight into substrate recognition and catalytic mechanism; single study","pmids":["40841561"],"is_preprint":false},{"year":2025,"finding":"UFL1 loss decreases METTL16 UFMylation, which reduces METTL16 ubiquitination and increases its protein stability. Stabilized METTL16 installs m6A on EEF1A1 mRNA, activating the IGF2BP1 axis to increase EEF1A1 protein levels and enhance resistance to enzalutamide-induced apoptosis in prostate cancer.","method":"Co-immunoprecipitation, MeRIP for EEF1A1 m6A, RIP for IGF2BP1, overexpression/knockdown experiments, in vitro and in vivo xenograft models","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — Co-IP and MeRIP identifying UFMylation as PTM controlling METTL16 stability; single lab with multiple assays","pmids":["41608626"],"is_preprint":false},{"year":2024,"finding":"Aminothiazolone compounds were identified as first-in-class small-molecule inhibitors of METTL16 that disrupt METTL16-RNA protein-RNA interaction at single-digit micromolar potency, validated by fluorescence-polarization screening and structural optimization.","method":"Fluorescence-polarization (FP)-based screening, medicinal chemistry optimization, cellular m6A modulation assays","journal":"JACS Au","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — FP binding assay plus cellular validation; single lab; establishes RNA-binding surface as druggable","pmids":["38665670"],"is_preprint":false},{"year":2023,"finding":"METTL16 controls KSHV lytic replication by promoting m6A modification and splicing/maturation of MAT2A transcript, thereby maintaining intracellular SAM levels and redox homeostasis (glutathione levels); SAM treatment is sufficient to inhibit KSHV lytic replication and reverse the effect of METTL16 knockdown.","method":"siRNA knockdown, SAM supplementation, MAT2A inhibitor treatment, ROS and glutathione measurements, KSHV lytic gene expression analysis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — epistasis established by SAM rescue of METTL16 knockdown phenotype; single lab with multiple complementary approaches","pmids":["37673880"],"is_preprint":false},{"year":2024,"finding":"METTL16 collaborates with IGF2BP2 to modulate SENP3 mRNA stability in an m6A-dependent manner; SENP3 in turn impedes proteasome-mediated ubiquitination/degradation of Lactotransferrin (LTF) via de-SUMOylation, elevating LTF to chelate free iron and reduce labile iron pool, conferring ferroptosis resistance in HCC.","method":"MeRIP-qPCR, RIP-qPCR, Co-IP, mass spectrometry, luciferase assay, hepatocyte-specific Mettl16 KO and OE mice, HCC organoids, xenografts","journal":"Journal of hematology & oncology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP and MeRIP plus in vivo KO/OE models and organoids establishing the mechanistic axis; single lab, multiple orthogonal methods","pmids":["39218945"],"is_preprint":false}],"current_model":"METTL16 is a SAM-dependent N6-methyladenosine (m6A) RNA methyltransferase with a Rossmann-fold catalytic domain and a C-terminal vertebrate-conserved/KA-1 domain that recruits U6 snRNA via its internal stem-loop; upon SAM binding, U6 snRNA undergoes conformational rearrangement for productive m6A modification at A43 (critical for 5' splice site recognition); in the nucleus METTL16 also methylates structured hairpins in the MAT2A 3' UTR, and its catalytic efficiency sets the intracellular SAM setpoint by modulating MAT2A intron retention—under SAM-limiting conditions, slow enzymatic turnover increases METTL16 occupancy on MAT2A hp1, promoting splicing and SAM synthetase induction; in the cytoplasm, METTL16 promotes translation initiation in an m6A-independent manner by interacting with eIF3a/b and sequestering the translational repressor eIF4E2; additionally, METTL16 interacts with MRE11 through RNA to inhibit DNA end resection until ATM-mediated phosphorylation at Ser329/conformational change releases this inhibition, linking METTL16 to homologous recombination control; post-translational modifications (lactylation at K229 by copper/metabolic stress, UFMylation by UFL1, phosphorylation at Ser329 by CDK13) tune its activity and stability; collectively, these m6A-dependent and independent functions of METTL16 govern SAM homeostasis, splicing, translation, genome integrity, and cell fate decisions including spermatogenesis, erythropoiesis, and embryonic development."},"narrative":{"mechanistic_narrative":"METTL16 is a SAM-dependent N6-methyladenosine (m6A) RNA methyltransferase that uses a Class I Rossmann-fold catalytic domain to recognize structured RNA substrates in which the target adenosine is presented in a bulge or hairpin [PMID:28525753, PMID:30197299, PMID:29593291]. It methylates A43 within the ACAGAGA box of U6 spliceosomal snRNA—a position that base-pairs with 5' splice sites—linking the enzyme directly to splice site recognition [PMID:29051200, PMID:37787376]. A C-terminal vertebrate-conserved KA-1-like domain recruits U6 snRNA through its internal stem-loop, and SAM binding to the catalytic pocket triggers a conformational rearrangement that repositions the target adenosine for productive catalysis [PMID:32266935, PMID:40841561]. Its kinetic mechanism is ordered-sequential, with RNA binding preceding SAM, and slow catalytic turnover underlies a regulatory function: METTL16 methylates conserved hairpins in the MAT2A 3' UTR, and under SAM-limiting conditions increased occupancy on hp1 promotes splicing of a retained intron to induce the SAM synthetase MAT2A, making METTL16 catalytic efficiency the determinant of the intracellular SAM setpoint [PMID:28525753, PMID:36584291, PMID:40644296]. Its mRNA m6A marks are decoded by reader proteins (YTHDC1, YTHDF2, IGF2BP1, YTHDC2) to control transcript stability and fate across diverse settings including metabolic reprogramming, hematopoiesis, and cell cycle progression [PMID:29262316, PMID:36795489, PMID:38605226, PMID:41680470]. Beyond catalysis, METTL16 acts through m6A-independent routes: in the cytosol it engages eIF3a/eIF3b and rRNA to promote translation-initiation complex assembly and sequesters the repressor eIF4E2 to favor cap recognition, while in the nucleus it binds MRE11 via RNA to restrain DNA end resection until ATM-dependent phosphorylation at Ser329 relieves this inhibition, linking the protein to homologous recombination and genome integrity [PMID:35145225, PMID:36840945, PMID:36138131]. METTL16 is essential in vivo, with loss causing peri-implantation embryonic lethality and defects in spermatogenesis, meiosis, and erythropoiesis [PMID:30197299, PMID:39030605, PMID:39607422, PMID:36307435]. Its activity and stability are tuned by post-translational modifications including lactylation at K229, CDK13-mediated Ser329 phosphorylation, and UFL1-dependent UFMylation [PMID:37863889, PMID:41680470, PMID:41608626].","teleology":[{"year":2017,"claim":"Established METTL16's core identity as the m6A writer for U6 snRNA and for the MAT2A 3' UTR, defining its dual role in splicing and SAM homeostasis.","evidence":"In vitro methylation with recombinant enzyme, knockdown, splicing/intron-retention assays, methionine starvation; CRAC mapping and co-IP of U6 biogenesis factors","pmids":["28525753","29051200"],"confidence":"High","gaps":["Did not resolve the structural basis of substrate selection","Reader proteins decoding MAT2A m6A not yet defined"]},{"year":2017,"claim":"Identified YTHDC1 as the reader linking METTL16-deposited m6A on MAT2A to SAM-responsive regulation, connecting the writer to a downstream effector.","evidence":"In vitro methylation, siRNA of METTL16 and YTHDC1, mutagenesis of target sites, mRNA stability assays","pmids":["29262316"],"confidence":"High","gaps":["Relative contributions of stability versus splicing regulation not fully partitioned","Redundancy among multiple target adenosines limits site-resolution dissection"]},{"year":2018,"claim":"Solved crystal structures revealing how the methyltransferase domain reads structured RNA with the target adenosine in a bulge, and demonstrated an in vivo requirement via embryonic lethality of knockout mice.","evidence":"X-ray crystallography of apo, SAH-bound, and MAT2A-RNA-bound forms; SEC and gel-shift; Mettl16 knockout mouse embryos with RNA-seq","pmids":["30197299","30197297","29593291"],"confidence":"High","gaps":["The C-terminal VCR/KA-1 contribution to U6 recognition was not captured","Oligomeric state in functional context partially unresolved"]},{"year":2020,"claim":"Defined how the vertebrate-conserved KA-1-like domain recruits U6 snRNA and remodels the A43 region for productive catalysis, explaining substrate-specific activation.","evidence":"Structural analysis, RNA-binding assays, MTD-KA1 chimera methylation assays, mutagenesis of the VCR basic region","pmids":["32266935"],"confidence":"High","gaps":["Atomic detail of the SAM-triggered rearrangement awaited later cryo-EM","Generalization of VCR function to other substrates unaddressed"]},{"year":2020,"claim":"Revealed METTL16 as substantially cytoplasmic and cell-cycle-regulated in its nuclear distribution, foreshadowing functions beyond nuclear m6A writing.","evidence":"Biochemical fractionation, endogenous vs FLAG-tagged IP; live imaging across cell cycle with co-IP of LBR, Lap2alpha, DDB2, and nucleolar proteins","pmids":["31940410","34357041"],"confidence":"Medium","gaps":["Functional consequence of cytoplasmic pool not established at this stage","Co-IP partners (LBR, Lap2alpha, DDB2) lack reciprocal/functional validation"]},{"year":2022,"claim":"Uncovered m6A-independent cytoplasmic functions: METTL16 promotes translation initiation via eIF3a/eIF3b and rRNA binding and by sequestering the repressor eIF4E2 to favor cap recognition.","evidence":"Reciprocal Co-IP of eIF3a/b and eIF4E2, ribosome/polysome profiling, m6A-seq, methyltransferase-dead complementation, cap-binding assays","pmids":["35145225","36840945"],"confidence":"High","gaps":["How nuclear writer and cytoplasmic translation roles are partitioned mechanistically is unclear","Direct structural basis of eIF interactions not resolved"]},{"year":2022,"claim":"Linked METTL16 to genome integrity through an RNA-mediated, catalysis-independent interaction with MRE11 that gates DNA end resection and is released by ATM phosphorylation at Ser329.","evidence":"Co-IP, in vitro exonuclease assays with recombinant proteins, ATM kinase assays, phosphomimetic/phospho-dead mutants","pmids":["36138131"],"confidence":"High","gaps":["Identity of the bridging RNA species not defined","Structural model of the METTL16-RNA-MRE11 complex absent"]},{"year":2022,"claim":"Demonstrated m6A-dependent control of metabolism and stem cell fate, with METTL16 driving BCAA reprogramming in AML and safeguarding genome integrity during erythropoiesis.","evidence":"CRISPR screens, conditional/genetic depletion in AML mouse models and erythroid cells, m6A-seq, RIP-seq, metabolic profiling, pairwise CRISPRi screen","pmids":["36608679","36307435"],"confidence":"High","gaps":["Direct versus indirect effects on individual target transcripts not fully separated","Role of MTR4-exosome in shaping the substrate pool incompletely defined"]},{"year":2022,"claim":"Established METTL16's kinetic mechanism as ordered-sequential (RNA before SAM) with slow turnover, providing the biochemical basis for its SAM-sensing regulatory behavior.","evidence":"Kd measurements, preincubation/isotope partitioning, steady-state and single-turnover kinetics","pmids":["36584291"],"confidence":"High","gaps":["Connection of measured kinetics to cellular SAM setpoint awaited later work","MALAT1 triple helix bound but not methylated, leaving its role unexplained"]},{"year":2022,"claim":"Showed PTM control and reader-dependent target regulation, with lactylation at K229 (inhibited by SIRT2) enhancing FDX1 m6A and YTHDF2-mediated MCP1 degradation extending the m6A output to inflammation and cuproptosis.","evidence":"MS identification of lactylation, SIRT2 manipulation, MeRIP, RIP for YTHDF2/readers, stability and functional assays","pmids":["37863889","36795489"],"confidence":"Medium","gaps":["Stoichiometry and generality of K229 lactylation not established","Whether PTMs alter catalytic versus non-catalytic functions unresolved"]},{"year":2024,"claim":"Defined developmental and germline roles via conditional knockouts, showing METTL16 controls splicing and translation of meiotic genes, MSCI, spermatogonial differentiation, and HSPC cell cycle.","evidence":"Germline/spermatocyte and zebrafish conditional knockouts, m6A-seq, RNA-seq, ribosome profiling, co-IP with splicing factors and MDC1/SCML2, activity-mutant rescue, RIP for IGF2BP1","pmids":["39030605","39607422","38605226","39614650"],"confidence":"High","gaps":["Tissue-specific substrate repertoires only partially mapped","Mechanism coupling splicing-factor interactions to specific exon choices not fully defined"]},{"year":2024,"claim":"Identified additional PTM writers and cofactors—CDK13 phosphorylation at Ser329 boosting activity, UFL1-dependent UFMylation controlling stability, and SSB acting as an RNA-binding cofactor and substrate.","evidence":"In vitro kinase assays, phosphomimetic mutants, MeRIP, Co-IP, RIP for readers, knockdown/overexpression in cancer models","pmids":["41680470","41608626","40580478"],"confidence":"Medium","gaps":["Interplay among Ser329 phosphorylation, UFMylation, and lactylation not integrated","Endogenous cofactor stoichiometry of SSB unknown"]},{"year":2025,"claim":"Demonstrated that METTL16 catalytic efficiency itself sets the intracellular SAM setpoint and resolved the cryo-EM mechanism of U6 recognition and SAM-triggered substrate repositioning.","evidence":"Degron depletion/complementation with hyperactive and dead mutants, SAM and methylation measurements, MTAP deletion; cryo-EM of METTL16-U6 snRNA complex","pmids":["40644296","40841561"],"confidence":"High","gaps":["Whether catalytic-efficiency tuning is exploited therapeutically remains untested","Structural basis for mRNA hairpin recognition versus U6 not directly compared"]},{"year":null,"claim":"How METTL16 partitions between its m6A-writer, translation-promoting, and DNA-repair functions, and how its many PTMs are coordinated to select among these activities, remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified model integrating catalytic and non-catalytic roles","Bridging RNAs in non-catalytic complexes (e.g., MRE11) unidentified","Cell-type-specific determinants of substrate choice undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,1,2,4,16,27]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,5,9,10,16]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,17,27]},{"term_id":"GO:0045182","term_label":"translation regulator activity","supporting_discovery_ids":[9,11]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,8,9]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7,9,11]},{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,1,2,27]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,12,26]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[9,11,19]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[10,15]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,20,21,22]}],"complexes":[],"partners":["MRE11","EIF3A","EIF3B","EIF4E2","YTHDC1","LARP7","MEPCE","SSB"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q86W50","full_name":"RNA N(6)-adenosine-methyltransferase METTL16","aliases":["Methyltransferase 10 domain-containing protein","Methyltransferase-like protein 16","U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase"],"length_aa":562,"mass_kda":63.6,"function":"RNA N6-methyltransferase that methylates adenosine residues at the N(6) position of a subset of RNAs and is involved in S-adenosyl-L-methionine homeostasis by regulating expression of MAT2A transcripts (PubMed:28525753, PubMed:30197297, PubMed:30197299, PubMed:33428944, PubMed:33930289). Able to N6-methylate a subset of mRNAs and U6 small nuclear RNAs (U6 snRNAs) (PubMed:28525753). In contrast to the METTL3-METTL14 heterodimer, only able to methylate a limited number of RNAs: requires both a 5'UACAGAGAA-3' nonamer sequence and a specific RNA structure (PubMed:28525753, PubMed:30197297, PubMed:30197299). Plays a key role in S-adenosyl-L-methionine homeostasis by mediating N6-methylation of MAT2A mRNAs, altering splicing of MAT2A transcripts: in presence of S-adenosyl-L-methionine, binds the 3'-UTR region of MAT2A mRNA and specifically N6-methylates the first hairpin of MAT2A mRNA, preventing recognition of their 3'-splice site by U2AF1/U2AF35, thereby inhibiting splicing and protein production of S-adenosylmethionine synthase (PubMed:28525753, PubMed:33930289). In S-adenosyl-L-methionine-limiting conditions, binds the 3'-UTR region of MAT2A mRNA but stalls due to the lack of a methyl donor, preventing N6-methylation and promoting expression of MAT2A (PubMed:28525753). In addition to mRNAs, also able to mediate N6-methylation of U6 small nuclear RNA (U6 snRNA): specifically N6-methylates adenine in position 43 of U6 snRNAs (PubMed:28525753, PubMed:29051200, PubMed:32266935). Also able to bind various lncRNAs, such as 7SK snRNA (7SK RNA) or 7SL RNA (PubMed:29051200). Specifically binds the 3'-end of the MALAT1 long non-coding RNA (PubMed:27872311)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q86W50/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/METTL16","classification":"Common Essential","n_dependent_lines":1171,"n_total_lines":1208,"dependency_fraction":0.9693708609271523},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CPSF6","stoichiometry":0.2},{"gene":"SSB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/METTL16","total_profiled":1310},"omim":[],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/METTL16"},"hgnc":{"alias_symbol":["MGC3329"],"prev_symbol":["METT10D"]},"alphafold":{"accession":"Q86W50","domains":[{"cath_id":"3.40.50.150","chopping":"5-289","consensus_level":"high","plddt":92.3803,"start":5,"end":289},{"cath_id":"3.30.310.80","chopping":"313-381_513-561","consensus_level":"high","plddt":87.0205,"start":313,"end":561}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86W50","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86W50-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86W50-F1-predicted_aligned_error_v6.png","plddt_mean":78.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=METTL16","jax_strain_url":"https://www.jax.org/strain/search?query=METTL16"},"sequence":{"accession":"Q86W50","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86W50.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86W50/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86W50"}},"corpus_meta":[{"pmid":"28525753","id":"PMC_28525753","title":"The U6 snRNA m6A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/28525753","citation_count":934,"is_preprint":false},{"pmid":"29051200","id":"PMC_29051200","title":"Human METTL16 is a N6-methyladenosine (m6A) methyltransferase that targets pre-mRNAs and various non-coding RNAs.","date":"2017","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/29051200","citation_count":553,"is_preprint":false},{"pmid":"37863889","id":"PMC_37863889","title":"Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37863889","citation_count":400,"is_preprint":false},{"pmid":"30197299","id":"PMC_30197299","title":"Methylation of Structured RNA by the m6A Writer METTL16 Is Essential for Mouse Embryonic Development.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30197299","citation_count":314,"is_preprint":false},{"pmid":"29262316","id":"PMC_29262316","title":"S-Adenosylmethionine Synthesis Is Regulated by Selective N6-Adenosine Methylation and mRNA Degradation Involving METTL16 and YTHDC1.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29262316","citation_count":302,"is_preprint":false},{"pmid":"35145225","id":"PMC_35145225","title":"METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis.","date":"2022","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/35145225","citation_count":284,"is_preprint":false},{"pmid":"30197297","id":"PMC_30197297","title":"Structural Basis for Regulation of METTL16, an S-Adenosylmethionine Homeostasis Factor.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/30197297","citation_count":191,"is_preprint":false},{"pmid":"36608679","id":"PMC_36608679","title":"METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism.","date":"2023","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/36608679","citation_count":141,"is_preprint":false},{"pmid":"34227247","id":"PMC_34227247","title":"RNA methyltransferase METTL16: Targets and function.","date":"2021","source":"Wiley interdisciplinary reviews. RNA","url":"https://pubmed.ncbi.nlm.nih.gov/34227247","citation_count":119,"is_preprint":false},{"pmid":"35596159","id":"PMC_35596159","title":"METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner.","date":"2022","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/35596159","citation_count":107,"is_preprint":false},{"pmid":"29593291","id":"PMC_29593291","title":"Structural insights into the RNA methyltransferase domain of METTL16.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29593291","citation_count":98,"is_preprint":false},{"pmid":"34075693","id":"PMC_34075693","title":"METTL16 promotes cell proliferation by up-regulating cyclin D1 expression in gastric cancer.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34075693","citation_count":96,"is_preprint":false},{"pmid":"32266935","id":"PMC_32266935","title":"Mechanistic insights into m6A modification of U6 snRNA by human METTL16.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32266935","citation_count":94,"is_preprint":false},{"pmid":"33671635","id":"PMC_33671635","title":"METTL16, Methyltransferase-Like Protein 16: Current Insights into Structure and Function.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33671635","citation_count":87,"is_preprint":false},{"pmid":"35259473","id":"PMC_35259473","title":"PM2.5 induces pulmonary microvascular injury in COPD via METTL16-mediated m6A modification.","date":"2022","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/35259473","citation_count":78,"is_preprint":false},{"pmid":"38302992","id":"PMC_38302992","title":"METTL16 promotes liver cancer stem cell self-renewal via controlling ribosome biogenesis and mRNA translation.","date":"2024","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38302992","citation_count":72,"is_preprint":false},{"pmid":"37340443","id":"PMC_37340443","title":"METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/37340443","citation_count":65,"is_preprint":false},{"pmid":"36138131","id":"PMC_36138131","title":"METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma.","date":"2022","source":"Nature cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36138131","citation_count":59,"is_preprint":false},{"pmid":"31940410","id":"PMC_31940410","title":"Characterization of METTL16 as a cytoplasmic RNA binding protein.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31940410","citation_count":59,"is_preprint":false},{"pmid":"36434904","id":"PMC_36434904","title":"METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36434904","citation_count":59,"is_preprint":false},{"pmid":"39218945","id":"PMC_39218945","title":"METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma.","date":"2024","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/39218945","citation_count":58,"is_preprint":false},{"pmid":"36840945","id":"PMC_36840945","title":"METTL16 promotes translation and lung tumorigenesis by sequestering cytoplasmic eIF4E2.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36840945","citation_count":53,"is_preprint":false},{"pmid":"28803425","id":"PMC_28803425","title":"Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers.","date":"2017","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/28803425","citation_count":47,"is_preprint":false},{"pmid":"36307435","id":"PMC_36307435","title":"The N6-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36307435","citation_count":42,"is_preprint":false},{"pmid":"38385084","id":"PMC_38385084","title":"METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway.","date":"2024","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38385084","citation_count":36,"is_preprint":false},{"pmid":"38334797","id":"PMC_38334797","title":"METTL16 inhibits papillary thyroid cancer tumorigenicity through m6A/YTHDC2/SCD1-regulated lipid metabolism.","date":"2024","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/38334797","citation_count":36,"is_preprint":false},{"pmid":"35069973","id":"PMC_35069973","title":"Oxidative Stress Aggravates Apoptosis of Nucleus Pulposus Cells through m6A Modification of MAT2A Pre-mRNA by METTL16.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/35069973","citation_count":35,"is_preprint":false},{"pmid":"39030605","id":"PMC_39030605","title":"N6-methyladenosine writer METTL16-mediated alternative splicing and translation control are essential for murine spermatogenesis.","date":"2024","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/39030605","citation_count":30,"is_preprint":false},{"pmid":"37817227","id":"PMC_37817227","title":"The RNA methyltransferase METTL16 enhances cholangiocarcinoma growth through PRDM15-mediated FGFR4 expression.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/37817227","citation_count":28,"is_preprint":false},{"pmid":"36518278","id":"PMC_36518278","title":"METTL16-mediated translation of CIDEA promotes non-alcoholic fatty liver disease progression via m6A-dependent manner.","date":"2022","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/36518278","citation_count":24,"is_preprint":false},{"pmid":"38089592","id":"PMC_38089592","title":"Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1α/METTL16/lnc-CSMD1-7/RBFOX2 axis.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38089592","citation_count":24,"is_preprint":false},{"pmid":"36158188","id":"PMC_36158188","title":"METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/36158188","citation_count":23,"is_preprint":false},{"pmid":"36307396","id":"PMC_36307396","title":"Knockdown of METTL16 disrupts learning and memory by reducing the stability of MAT2A mRNA.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/36307396","citation_count":22,"is_preprint":false},{"pmid":"36584291","id":"PMC_36584291","title":"Elucidating the Kinetic Mechanism of Human METTL16.","date":"2022","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36584291","citation_count":21,"is_preprint":false},{"pmid":"38605226","id":"PMC_38605226","title":"A Mettl16/m6A/mybl2b/Igf2bp1 axis ensures cell cycle progression of embryonic hematopoietic stem and progenitor cells.","date":"2024","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/38605226","citation_count":20,"is_preprint":false},{"pmid":"33143367","id":"PMC_33143367","title":"The Distinct Function and Localization of METTL3/METTL14 and METTL16 Enzymes in Cardiomyocytes.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33143367","citation_count":20,"is_preprint":false},{"pmid":"37647025","id":"PMC_37647025","title":"m6A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/37647025","citation_count":20,"is_preprint":false},{"pmid":"37673880","id":"PMC_37673880","title":"METTL16 controls Kaposi's sarcoma-associated herpesvirus replication by regulating S-adenosylmethionine cycle.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37673880","citation_count":17,"is_preprint":false},{"pmid":"37927399","id":"PMC_37927399","title":"METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/β-Catenin Axis.","date":"2023","source":"Analytical cellular pathology (Amsterdam)","url":"https://pubmed.ncbi.nlm.nih.gov/37927399","citation_count":17,"is_preprint":false},{"pmid":"38927271","id":"PMC_38927271","title":"RNA Binding by the m6A Methyltransferases METTL16 and METTL3.","date":"2024","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/38927271","citation_count":16,"is_preprint":false},{"pmid":"39405702","id":"PMC_39405702","title":"m6A RNA methyltransferase METTL16 induces Cr(VI) carcinogenesis and lung cancer development through glutamine biosynthesis and GLUL expression.","date":"2024","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/39405702","citation_count":16,"is_preprint":false},{"pmid":"37357526","id":"PMC_37357526","title":"METTL16 promotes osteosarcoma progression by downregulating VPS33B in an m6 A-dependent manner.","date":"2023","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37357526","citation_count":16,"is_preprint":false},{"pmid":"38084791","id":"PMC_38084791","title":"METTL16-mediated N6-methyladenosine modification of Soga1 enables proper chromosome segregation and chromosomal stability in colorectal cancer.","date":"2023","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/38084791","citation_count":16,"is_preprint":false},{"pmid":"38665670","id":"PMC_38665670","title":"Aminothiazolone Inhibitors Disrupt the Protein-RNA Interaction of METTL16 and Modulate the m6A RNA Modification.","date":"2024","source":"JACS Au","url":"https://pubmed.ncbi.nlm.nih.gov/38665670","citation_count":14,"is_preprint":false},{"pmid":"37182151","id":"PMC_37182151","title":"The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37182151","citation_count":14,"is_preprint":false},{"pmid":"36406135","id":"PMC_36406135","title":"METTL16 regulates m6A methylation on chronic hepatitis B associated gene HLA-DPB1 involved in liver fibrosis.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36406135","citation_count":14,"is_preprint":false},{"pmid":"38045858","id":"PMC_38045858","title":"METTL16 in human diseases: What should we do next?","date":"2023","source":"Open medicine (Warsaw, Poland)","url":"https://pubmed.ncbi.nlm.nih.gov/38045858","citation_count":13,"is_preprint":false},{"pmid":"37787376","id":"PMC_37787376","title":"Inter-species association mapping links splice site evolution to METTL16 and SNRNP27K.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37787376","citation_count":13,"is_preprint":false},{"pmid":"39061113","id":"PMC_39061113","title":"METTL16 regulates the mRNA stability of FBXO5 via m6A modification to facilitate the malignant behavior of breast cancer.","date":"2024","source":"Cancer & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/39061113","citation_count":13,"is_preprint":false},{"pmid":"39247832","id":"PMC_39247832","title":"METTL16 Promotes Stability of SYNPO2L mRNA and leading to Cancer Cell Lung Metastasis by Secretion of COL10A1 and attract the Cancer-Associated Fibroblasts.","date":"2024","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39247832","citation_count":12,"is_preprint":false},{"pmid":"36795489","id":"PMC_36795489","title":"The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment.","date":"2023","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/36795489","citation_count":12,"is_preprint":false},{"pmid":"40194654","id":"PMC_40194654","title":"RNA methyltransferase METTL16: From molecular mechanisms to therapeutic prospects in cancers.","date":"2025","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/40194654","citation_count":11,"is_preprint":false},{"pmid":"39744432","id":"PMC_39744432","title":"METTL16 suppresses ferroptosis in cholangiocarcinoma by promoting ATF4 via m6A modification.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39744432","citation_count":11,"is_preprint":false},{"pmid":"34357041","id":"PMC_34357041","title":"Localization of METTL16 at the Nuclear Periphery and the Nucleolus Is Cell Cycle-Specific and METTL16 Interacts with Several Nucleolar Proteins.","date":"2021","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34357041","citation_count":9,"is_preprint":false},{"pmid":"37859814","id":"PMC_37859814","title":"Suppression of Wnt/β-catenin Signaling in PDAC via METTL16-mediated N6-methyladenosine Modification of DVL2.","date":"2023","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37859814","citation_count":9,"is_preprint":false},{"pmid":"39434688","id":"PMC_39434688","title":"METTL16 inhibits pancreatic cancer proliferation and metastasis by promoting MROH8 RNA stability and inhibiting CAPN2 expression - experimental studies.","date":"2024","source":"International journal of surgery (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/39434688","citation_count":8,"is_preprint":false},{"pmid":"39418792","id":"PMC_39418792","title":"METTL16 inhibits differentiation and promotes proliferation and slow myofibers formation in chicken myoblasts.","date":"2024","source":"Poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/39418792","citation_count":8,"is_preprint":false},{"pmid":"39756795","id":"PMC_39756795","title":"The promoting effect of the POU3F2/METTL16/PFKM cascade on glycolysis and tumorigenesis of hepatocellular carcinoma.","date":"2025","source":"Annals of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/39756795","citation_count":8,"is_preprint":false},{"pmid":"37018281","id":"PMC_37018281","title":"Brute Force Virtual Drug Screening with Molecular Dynamics Simulation and MM/PBSA to Find Potent Inhibitors of METTL16.","date":"2023","source":"IEEE/ACM transactions on computational biology and bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/37018281","citation_count":8,"is_preprint":false},{"pmid":"39607422","id":"PMC_39607422","title":"METTL16 is Required for Meiotic Sex Chromosome Inactivation and DSB Formation and Recombination during Male Meiosis.","date":"2024","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/39607422","citation_count":7,"is_preprint":false},{"pmid":"37085020","id":"PMC_37085020","title":"METTL16, an evolutionarily conserved m6A methyltransferase member, inhibits the antiviral immune response of miiuy croaker (Miichthys miiuy).","date":"2023","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37085020","citation_count":7,"is_preprint":false},{"pmid":"38092148","id":"PMC_38092148","title":"Global RNA modifications to the MALAT1 triple helix differentially affect thermostability and weaken binding to METTL16.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38092148","citation_count":7,"is_preprint":false},{"pmid":"40210616","id":"PMC_40210616","title":"Role of METTL16 in PPARγ methylation and osteogenic differentiation.","date":"2025","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/40210616","citation_count":6,"is_preprint":false},{"pmid":"39614650","id":"PMC_39614650","title":"METTL16 and YTHDC1 Regulate Spermatogonial Differentiation via m6A.","date":"2024","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/39614650","citation_count":6,"is_preprint":false},{"pmid":"37504262","id":"PMC_37504262","title":"RNA Methyltransferase METTL16's Protein Domains Have Differential Functional Effects on Cell Processes.","date":"2023","source":"Current issues in molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/37504262","citation_count":6,"is_preprint":false},{"pmid":"39150226","id":"PMC_39150226","title":"Methyl-Transferase-Like Protein 16 (METTL16): The Intriguing Journey of a Key Epitranscriptomic Player Becoming an Emerging Biological Target.","date":"2024","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39150226","citation_count":6,"is_preprint":false},{"pmid":"40644296","id":"PMC_40644296","title":"The catalytic efficiency of METTL16 affects cellular processes by governing the intracellular S-adenosylmethionine setpoint.","date":"2025","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/40644296","citation_count":5,"is_preprint":false},{"pmid":"38520913","id":"PMC_38520913","title":"METTL16 deficiency attenuates apoptosis through translational control of extrinsic death receptor during nutrient deprivation.","date":"2024","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/38520913","citation_count":5,"is_preprint":false},{"pmid":"40251670","id":"PMC_40251670","title":"METTL16/IGF2BP2 axis enhances malignant progression and DDP resistance through up-regulating COL4A1 by mediating the m6A methylation modification of LAMA4 in hepatocellular carcinoma.","date":"2025","source":"Cell division","url":"https://pubmed.ncbi.nlm.nih.gov/40251670","citation_count":5,"is_preprint":false},{"pmid":"39362437","id":"PMC_39362437","title":"Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39362437","citation_count":5,"is_preprint":false},{"pmid":"40299085","id":"PMC_40299085","title":"m6A hypermethylation of TCF-1 regulated by METTL16 promotes acute myeloid leukemia.","date":"2025","source":"Clinical and experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40299085","citation_count":5,"is_preprint":false},{"pmid":"40095756","id":"PMC_40095756","title":"The Oncogenic Role of UBXN1 in Gastric Cancer Is Attributed to the METTL16-Mediated m6A Methylation and Histone Modifications.","date":"2025","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40095756","citation_count":5,"is_preprint":false},{"pmid":"40841561","id":"PMC_40841561","title":"Structures and mechanisms of U6 snRNA m6A modification by METTL16.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/40841561","citation_count":4,"is_preprint":false},{"pmid":"39667326","id":"PMC_39667326","title":"METTL16 controls airway inflammations in smoking-induced COPD via regulating glutamine metabolism.","date":"2024","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/39667326","citation_count":4,"is_preprint":false},{"pmid":"40308894","id":"PMC_40308894","title":"Effects of m6A methylation of MAT2A mRNA regulated by METTL16 on learning and memory, hippocampal synaptic plasticity and Aβ1-42 in 5 × FAD mice.","date":"2025","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/40308894","citation_count":4,"is_preprint":false},{"pmid":"40200229","id":"PMC_40200229","title":"METTL16-dependent miR-146b-5p m6A modification remodeling sensitize NSCLC to osimertinib via activating PI3K/AKT signaling.","date":"2025","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40200229","citation_count":4,"is_preprint":false},{"pmid":"37423176","id":"PMC_37423176","title":"Genetic Variations Within METTL16 and Susceptibility to Sudden Cardiac Death in Chinese Populations With Coronary Artery Disease.","date":"2023","source":"The American journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/37423176","citation_count":4,"is_preprint":false},{"pmid":"37274238","id":"PMC_37274238","title":"Corrigendum: The m6A methyltransferase METTL16 inhibits the proliferation of pancreatic adenocarcinoma cancer cells via the p21 signaling pathway.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37274238","citation_count":4,"is_preprint":false},{"pmid":"40860196","id":"PMC_40860196","title":"METTL16 Promotes Lipid Metabolic Reprogramming and Colorectal Cancer Progression.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40860196","citation_count":3,"is_preprint":false},{"pmid":"40946103","id":"PMC_40946103","title":"METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis.","date":"2025","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/40946103","citation_count":3,"is_preprint":false},{"pmid":"40517800","id":"PMC_40517800","title":"Norcantharidin inhibits the METTL16/MAT2A pathway to induce apoptosis and suppress tumor progression in ovarian cancer.","date":"2025","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/40517800","citation_count":3,"is_preprint":false},{"pmid":"40826028","id":"PMC_40826028","title":"METTL16-dependent GPX4 m6A modification links ferroptosis to NSCLC TKIs resistance.","date":"2025","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40826028","citation_count":3,"is_preprint":false},{"pmid":"40597047","id":"PMC_40597047","title":"Platycodin D-mediated METTL16 downregulation promotes docetaxel treatment of prostate cancer by regulating ferroptosis.","date":"2025","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40597047","citation_count":3,"is_preprint":false},{"pmid":"39088431","id":"PMC_39088431","title":"METTL16 participates in haemoglobin H disease through m6A modification.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/39088431","citation_count":3,"is_preprint":false},{"pmid":"40015977","id":"PMC_40015977","title":"Pan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer.","date":"2025","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/40015977","citation_count":3,"is_preprint":false},{"pmid":"40665962","id":"PMC_40665962","title":"Nanoformulations Downregulating METTL16 Combined with mRNA Tumor Vaccines Suppress Triple-Negative Breast Cancer and Prevent Metastasis.","date":"2025","source":"International journal of nanomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/40665962","citation_count":3,"is_preprint":false},{"pmid":"41322419","id":"PMC_41322419","title":"METTL16 emerges as a pivotal epitranscriptomic regulator, linking RNA modification, tumor progression, and immune modulation.","date":"2025","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41322419","citation_count":2,"is_preprint":false},{"pmid":"40580478","id":"PMC_40580478","title":"SSB cooperates with METTL16-mediated m6A RNA methylation to promote chemoresistance in colorectal cancer cells.","date":"2025","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/40580478","citation_count":2,"is_preprint":false},{"pmid":"41680470","id":"PMC_41680470","title":"CDK13 drives clear cell renal carcinoma through METTL16-mediated m6A modification of ACLY mRNA.","date":"2026","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41680470","citation_count":2,"is_preprint":false},{"pmid":"40186923","id":"PMC_40186923","title":"A novel cinnamic acid derivative for hepatocellular carcinoma therapy by degrading METTL16 protein.","date":"2025","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40186923","citation_count":2,"is_preprint":false},{"pmid":"39404474","id":"PMC_39404474","title":"Genetic Variants in METTL16 Affect the Risk of Non-Syndromic Orofacial Clefts.","date":"2024","source":"Birth defects research","url":"https://pubmed.ncbi.nlm.nih.gov/39404474","citation_count":2,"is_preprint":false},{"pmid":"40453970","id":"PMC_40453970","title":"METTL16 Contributes to Coronary Heart Disease by Inducing TET2 m6A Modification.","date":"2025","source":"Journal of inflammation research","url":"https://pubmed.ncbi.nlm.nih.gov/40453970","citation_count":1,"is_preprint":false},{"pmid":"40627260","id":"PMC_40627260","title":"METTL16 promotes progression of clear cell renal cell carcinoma via up-regulating N6-methyladenosine modification of KLK4 mRNA.","date":"2025","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/40627260","citation_count":1,"is_preprint":false},{"pmid":"41310324","id":"PMC_41310324","title":"Multi-omics and experimental validation identify methylation-related genes and METTL16 as key regulators in diabetic foot ulcer pathogenesis.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41310324","citation_count":1,"is_preprint":false},{"pmid":"38370381","id":"PMC_38370381","title":"Gene polymorphisms of METTL5 and METTL16 are related to epithelial ovarian cancer risk in South China: A three-center case-control study.","date":"2024","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/38370381","citation_count":1,"is_preprint":false},{"pmid":"41608626","id":"PMC_41608626","title":"Loss of UFL1 confers enzalutamide resistance of prostate tumors by regulating METTL16-mediated m6A modification of EEF1A1 mRNA.","date":"2026","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41608626","citation_count":1,"is_preprint":false},{"pmid":"39189039","id":"PMC_39189039","title":"Thrombopoietin improves the functions of bone marrow endothelial progenitor cells via METTL16/Akt signalling of haematological patients with chemotherapy-induced thrombocytopenia.","date":"2024","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/39189039","citation_count":1,"is_preprint":false},{"pmid":"41459114","id":"PMC_41459114","title":"METTL16 in cancer: Roles and regulatory mechanisms.","date":"2025","source":"Genes & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/41459114","citation_count":0,"is_preprint":false},{"pmid":"40639767","id":"PMC_40639767","title":"METTL16 promotes corneal nerve regeneration in diabetic corneal neuropathy.","date":"2025","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/40639767","citation_count":0,"is_preprint":false},{"pmid":"40405148","id":"PMC_40405148","title":"METTL16 accelerates lung adenocarcinoma progression by inducing N6-methyladenosine modification of GTSE1 to regulate p53 pathway and cell cycle.","date":"2025","source":"Cell division","url":"https://pubmed.ncbi.nlm.nih.gov/40405148","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52639,"output_tokens":8749,"usd":0.144576,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18316,"output_tokens":4996,"usd":0.10824,"stage2_stop_reason":"end_turn"},"total_usd":0.252816,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"METTL16 is the N6-methyladenosine (m6A) methyltransferase responsible for methylating the U6 spliceosomal snRNA, and it regulates MAT2A (SAM synthetase) expression by methylating a conserved hairpin (hp1) in the MAT2A 3' UTR. Under SAM-limiting conditions, increased METTL16 occupancy on hp1 due to inefficient enzymatic turnover promotes splicing of a retained intron in MAT2A pre-mRNA, thereby inducing MAT2A expression to restore SAM homeostasis.\",\n      \"method\": \"In vitro methylation assays with recombinant METTL16, siRNA knockdown, intron retention/splicing assays, methionine starvation experiments, mutational analysis of hairpin substrates\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (in vitro assays, mutagenesis, cellular knockdown, splicing assays) in a rigorous study; independently replicated by subsequent papers\",\n      \"pmids\": [\"28525753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"METTL16 is responsible for N6-methylation of A43 of the U6 snRNA and interacts with early U6 biogenesis factors La, LARP7, and the methylphosphate capping enzyme MEPCE. A43 lies within the ACAGAGA box of U6 that base-pairs with 5' splice sites during splicing, implicating this modification in splicing regulation.\",\n      \"method\": \"CRAC (crosslinking and analysis of cDNA), in vivo methylation assays, co-immunoprecipitation identifying La, LARP7, MEPCE as interaction partners\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRAC mapping plus co-IP of interaction partners, replicated across multiple labs confirming U6 A43 methylation\",\n      \"pmids\": [\"29051200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"METTL16-mediated m6A modification of the MAT2A 3' UTR is read by the m6A reader YTHDC1, and this METTL16-YTHDC1 axis controls SAM-responsive regulation of MAT2A mRNA stability. In vitro reactions with recombinant METTL16 identified multiple conserved methylation targets in the MAT2A 3' UTR, and mutations of these adenine sites revealed redundancy in regulation.\",\n      \"method\": \"In vitro methylation assays with recombinant METTL16, siRNA knockdown of METTL16 and YTHDC1, mutagenesis of m6A target sites, mRNA stability assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro reconstitution with recombinant protein, mutagenesis, and cellular knockdown in single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29262316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of human METTL16 reveals a methyltransferase domain with an extra N-terminal module forming a deep-cut groove essential for RNA binding, showing it selects for structured RNAs where the critical adenosine is present in a bulge. Mouse embryos lacking Mettl16 show reduced Mat2a mRNA levels, massive transcriptome dysregulation at the ~64-cell blastocyst stage, and failure of further development.\",\n      \"method\": \"X-ray crystallography, Mettl16 knockout mouse embryo analysis, RNA-seq of knockout embryos\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation and in vivo knockout phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"30197299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structures of METTL16 in complex with MAT2A RNA hairpins reveal atomic details of RNA substrate recognition for productive methylation. A polypeptide loop near the SAM binding site has an autoregulatory role; mutations that enhance or repress METTL16 activity in vitro correlate with changes in MAT2A mRNA levels in cells.\",\n      \"method\": \"X-ray crystallography of METTL16-RNA complexes, in vitro methylation assays, mutagenesis correlated with cellular MAT2A levels\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures with mutagenesis and in vitro/cellular validation in a single rigorous study\",\n      \"pmids\": [\"30197297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"X-ray crystal structures of the METTL16 N-terminal methyltransferase domain (residues 1-291) in apo form and SAH-bound complex reveal a Rossmann fold with a large positively charged groove as the RNA-binding site. Full-length METTL16 forms a homodimer and METTL16_291 is a monomer; the full-length protein but not the monomeric domain binds the MALAT1 RNA triple helix. The catalytic mechanism involves Class I SAM-dependent methyltransferase chemistry.\",\n      \"method\": \"X-ray crystallography (1.9 Å apo; 2.1 Å SAH complex), size-exclusion chromatography, native gel-shift assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures with biochemical validation (SEC, gel-shift), single lab with multiple orthogonal structural and biochemical methods\",\n      \"pmids\": [\"29593291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The vertebrate conserved region (VCR) of METTL16 increases affinity toward U6 snRNA via a conserved basic region, and is topologically homologous to the KA1 domain of TUT1. The VCR interacts with the internal stem-loop (ISL) of U6 snRNA, inducing conformational rearrangement of the A43-containing region to make it suitable for productive catalysis by the methyltransferase domain (MTD). A chimera of METTL16 MTD with TUT1 KA1 methylated U6 snRNA more efficiently than MTD alone.\",\n      \"method\": \"Structural analysis, RNA binding assays, chimeric protein construction and methylation assays, mutational analysis of VCR basic region\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — structural and functional analyses combined with chimeric protein reconstitution and mutagenesis in a single thorough study\",\n      \"pmids\": [\"32266935\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Biochemical fractionation reveals that a majority of METTL16 protein resides in the cytoplasm in multiple cell lines, in addition to the nucleus, suggesting METTL16 functions as a cytoplasmic RNA binding protein. Exogenously overexpressed METTL16 differs from endogenous protein in its relative affinity for RNA targets.\",\n      \"method\": \"Biochemical cell fractionation, immunoprecipitation of endogenous and FLAG-tagged METTL16, siRNA knockdown with mRNA target expression analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Weak — biochemical fractionation in single lab; single method for localization without full functional consequence established\",\n      \"pmids\": [\"31940410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"METTL16 nuclear distribution is cell cycle-specific: it accumulates in the nucleolus in G1/S phases, increases in the nucleoplasm in G2, is very low in metaphase/anaphase, and reappears at the nuclear lamina in telophase. METTL16 interacts with Lamin B Receptor (LBR) and Lap2α (but not A- or B-type lamins), with Lap2α depletion causing METTL16 downregulation. METTL16 also interacts with DDB2 (NER factor) and nucleolar proteins TCOF, NOLC1, and UBF1/2.\",\n      \"method\": \"Live cell imaging and immunofluorescence for cell cycle stages, co-immunoprecipitation for protein interactions, A-type lamin depletion experiments\",\n      \"journal\": \"Life (Basel, Switzerland)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — cell cycle-resolved localization by imaging plus Co-IP for multiple interaction partners, single lab\",\n      \"pmids\": [\"34357041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL16 exerts an m6A-independent function in the cytosol by directly interacting with eukaryotic initiation factors eIF3a and eIF3b as well as ribosomal RNA through its methyltransferase domain, thereby facilitating assembly of the translation-initiation complex and promoting translation of >4,000 mRNA transcripts. In the nucleus, METTL16 additionally functions as an m6A writer on hundreds of specific mRNA targets.\",\n      \"method\": \"Co-immunoprecipitation of eIF3a/eIF3b, ribosome profiling, m6A-seq, methyltransferase-dead mutant complementation, dual nuclear/cytoplasmic localization experiments\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP plus ribosome profiling and mutant complementation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"35145225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL16 interacts with MRE11 through RNA (in a methyltransferase-independent manner) and this interaction inhibits MRE11's exonuclease activity, thereby repressing DNA end resection. Upon DNA damage, ATM phosphorylates METTL16, causing a conformational change and autoinhibition of its RNA binding, which dissociates the METTL16-RNA-MRE11 complex and releases MRE11 to promote homologous recombination repair.\",\n      \"method\": \"Co-immunoprecipitation, in vitro exonuclease assays with recombinant proteins, ATM kinase assays, phosphomimetic/phospho-dead mutants, RNA-dependent interaction assays\",\n      \"journal\": \"Nature cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro exonuclease reconstitution, Co-IP, mutagenesis of phosphorylation sites, multiple orthogonal methods in single study\",\n      \"pmids\": [\"36138131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL16 promotes translation and lung tumorigenesis through an m6A-independent mechanism: cytoplasmic METTL16 directly interacts with eIF4E2, preventing eIF4E2 from competing with eIF4E for 5' cap binding, thereby promoting cap recognition by eIF4E and selective protein synthesis of key oncogenes.\",\n      \"method\": \"Co-immunoprecipitation of eIF4E2, cap-binding assays, methyltransferase-dead mutant analysis, siRNA depletion with polysome profiling, dual localization confirmed\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus functional assays with mutants, single lab; complements but partially overlaps with Su et al. 2022 finding on translation\",\n      \"pmids\": [\"36840945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL16 promotes expression of BCAT1 and BCAT2 in an m6A-dependent manner, reprogramming branched-chain amino acid (BCAA) metabolism to support AML leukemogenesis and leukemia stem cell self-renewal.\",\n      \"method\": \"CRISPR-Cas9 screening, genetic depletion in AML mouse models, m6A-seq, RIP-seq, metabolic profiling of BCAA metabolism\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR screen validated by genetic depletion in vivo, m6A-seq, and metabolic readouts; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"36608679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL16 is lactylated at site K229, a modification inhibited by SIRT2. Copper stress promotes METTL16 lactylation, which enhances METTL16-mediated m6A modification of FDX1 mRNA, promoting cuproptosis in gastric cancer.\",\n      \"method\": \"Mass spectrometry identification of lactylation sites, SIRT2 inhibition/overexpression, MeRIP for FDX1 m6A, in vitro and in vivo cuproptosis assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — MS identification of PTM site plus functional validation with writer/eraser (SIRT2) and downstream m6A target; multiple orthogonal methods in single study\",\n      \"pmids\": [\"37863889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL16 negatively regulates MCP1 expression in mesenchymal stem cells through m6A modification of MCP1 mRNA at the CDS region, which is recognized by the m6A reader YTHDF2 to promote MCP1 mRNA degradation, thereby controlling monocyte recruitment.\",\n      \"method\": \"siRNA knockdown, MeRIP (m6A-RIP), RIP for YTHDF2, mRNA stability assays, in vivo monocyte recruitment assay\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — MeRIP plus RIP and stability assays, identified specific CDS m6A sites; single lab\",\n      \"pmids\": [\"36795489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL16 is required for proper erythropoiesis by safeguarding genome integrity via m6A deposition on structured motifs in DNA-repair-related transcripts including Brca2 and Fancm mRNAs, upregulating their expression. A pairwise CRISPRi screen revealed that the MTR4-nuclear RNA exosome complex is involved in regulating METTL16 substrate mRNAs in erythroblasts.\",\n      \"method\": \"METTL16 conditional knockout in erythroid cells, m6A-seq, RNA-seq, pairwise CRISPRi screens, DNA damage markers\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined molecular phenotype, m6A-seq, genetic epistasis via CRISPRi screen; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"36307435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"METTL16 kinetic mechanism is ordered-sequential: METTL16 binds U6 snRNA before SAM. METTL16 is monomeric when in complex with MALAT1 triple helix or U6 snRNA, with dissociation constants of 31 nM (MALAT1) and 18 nM (U6 snRNA). The MALAT1 triple helix is not methylated by METTL16 under in vitro conditions. The kcat is 0.07 min-1 and kchem is 0.56 min-1; the VCR domains weaken the ternary complex but do not limit the rate of chemical catalysis.\",\n      \"method\": \"In vitro binding assays (Kd measurements), preincubation and isotope partitioning assays, steady-state and single-turnover kinetic assays\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — rigorous in vitro kinetic reconstitution with multiple complementary assay types establishing ordered mechanism; single lab\",\n      \"pmids\": [\"36584291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"METTL16 methylation consensus sequence is UACAGARAA (modified A underlined), and structural requirements exist for its known RNA interactors; the methyltransferase domain contains a Rossmann-like fold characteristic of class I SAM-dependent methyltransferases and uses SAM as the methyl donor.\",\n      \"method\": \"Review synthesizing structural and biochemical data (not primary experimental data in this paper)\",\n      \"journal\": \"Wiley interdisciplinary reviews. RNA\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Strong — review consolidating replicated experimental findings from multiple primary studies\",\n      \"pmids\": [\"34227247\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Inter-species association mapping links 5' splice site sequence preferences (particularly the +4 position adenosine vs. uridine preference) to the presence of METTL16 and SNRNP27K. Loss of METTL16 orthologs is associated with a preference for +4 U at 5' splice sites, consistent with the role of METTL16-mediated U6 snRNA m6A in splice site recognition.\",\n      \"method\": \"Inter-species association mapping across Saccharomycotina species, genetic analysis of METTL16/SNRNP27K mutants, splice site sequence analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cross-species genetic epistasis/association mapping with mutant validation; novel approach providing orthogonal evidence for U6 m6A function in splicing\",\n      \"pmids\": [\"37787376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL16 controls ribosomal RNA (rRNA) maturation and mRNA translation, and eIF3a mRNA is a bona fide m6A target of METTL16 in HCC. METTL16 depletion dramatically decreases liver cancer stem cell frequency in vitro and in vivo, and attenuates HCC initiation/progression in liver-specific knockout mice.\",\n      \"method\": \"Liver-specific conditional knockout mice, hydrodynamic tail-vein injection HCC model, RNA-seq, RIP-seq, ribosome profiling, limiting dilution assay, CRISPR tiling scan\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO mice with multiple in vivo models, ribosome profiling, RIP-seq identifying eIF3a as direct target; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38302992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL16 regulates alternative splicing of meiosis-related genes (e.g., Stag3) by interacting with splicing factors, and controls translation efficiency of meiotic genes; germline conditional knockout of Mettl16 in male mice impairs spermatogonial differentiation and meiosis initiation. The methyltransferase activity site (PP185-186AA) is necessary for spermatogenesis.\",\n      \"method\": \"Germline conditional knockout mice, m6A-seq, RNA-seq, ribosome profiling, in vivo/vitro methyltransferase mutant complementation, co-IP with splicing factors\",\n      \"journal\": \"Genome biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with multiple omics (m6A-seq, ribosome profiling) and mutagenesis validation; single lab with orthogonal methods\",\n      \"pmids\": [\"39030605\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL16 controls cell cycle progression of embryonic hematopoietic stem and progenitor cells by directly regulating mybl2b mRNA via m6A modification. Mettl16 deficiency destabilizes mybl2b mRNA, likely due to lost binding by the m6A reader Igf2bp1, causing G1/S cell cycle arrest. This METTL16-m6A-MYBL2-IGF2BP1 axis is conserved in humans.\",\n      \"method\": \"Mettl16-deficient zebrafish, single-cell RNA-seq, m6A-seq, RIP for Igf2bp1, cell cycle analysis, methyltransferase-activity mutant rescue experiments\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — zebrafish KO with m6A-seq, RIP, and activity-mutant rescue; cross-species conservation validated; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38605226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL16 is required for meiotic sex chromosome inactivation (MSCI), DSB formation, homologous recombination, and SYCP1 deposition during male meiosis. METTL16 interacts with MDC1/SCML2 to coordinate DNA damage response and XY body epigenetic modifications establishing MSCI; it also regulates m6A levels and translational efficiency of meiosis-related genes including Ubr2.\",\n      \"method\": \"METTL16 spermatocyte-specific knockout mice, multi-omics (m6A-seq, RNA-seq, ribosome profiling, proteomics), Co-IP with MDC1/SCML2\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with multi-omics and Co-IP of mechanistic partners; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"39607422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL16 and its reader YTHDC1 are required for spermatogonial differentiation; deletion of Mettl16 using Stra8-Cre causes blockade in spermatogonial differentiation and progressive loss of spermatogonia. RNA-seq and m6A-seq showed that loss of either METTL16 or YTHDC1 disrupts expression of genes related to chromosome organisation and segregation.\",\n      \"method\": \"Conditional knockout mice (Mettl16vasa-cre, Mettl16Stra8-cre, Ythdc1-sKO), RNA-seq, m6A-seq\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with omics; partial mechanistic follow-up; single lab\",\n      \"pmids\": [\"39614650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CDK13 directly phosphorylates METTL16 at Ser329, augmenting its catalytic activity to install m6A on ACLY mRNA. These m6A marks are recognized by YTHDC2, leading to ACLY mRNA stabilization, increased acetyl-CoA production, and lipogenesis in clear cell renal cell carcinoma.\",\n      \"method\": \"In vitro kinase assay (CDK13 phosphorylating METTL16), phosphomimetic/phospho-dead METTL16 mutants, MeRIP for ACLY m6A, RIP for YTHDC2, mRNA stability assays\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay plus mutagenesis and MeRIP in single lab; single study identifying PTM writer\",\n      \"pmids\": [\"41680470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SSB functions as a cofactor for METTL16 in installing m6A RNA methylation by enhancing METTL16 binding to RNA. SSB is itself a direct target of METTL16-mediated m6A RNA methylation, forming a positive auto-regulatory loop promoting m6A methylation, SSB expression, and chemoresistance.\",\n      \"method\": \"Co-immunoprecipitation, RNA binding assays, MeRIP for SSB mRNA, siRNA knockdown, chemoresistance assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP and MeRIP establishing SSB as cofactor and substrate; single lab; auto-regulatory loop supported by multiple methods\",\n      \"pmids\": [\"40580478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The catalytic efficiency of METTL16 governs the intracellular SAM setpoint: catalytically hyperactive METTL16 complements methyltransferase activities but decreases intracellular SAM concentrations by abrogating MAT2A regulation, making cells hypersensitive to MAT2A inhibition and MTAP deletion. U6 snRNA pseudogenes are identified as additional METTL16 substrates.\",\n      \"method\": \"Degron-based depletion and complementation strategy in HCT116 cells, hyperactive/catalytically-dead mutant METTL16 constructs, intracellular SAM measurement, histone methylation and RNA methylation assays, MTAP gene deletion\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — rigorous degron/complementation with mutant panel and metabolic readouts; demonstrates catalytic efficiency as direct regulator of SAM setpoint; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"40644296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures of METTL16 in complex with U6 snRNA reveal that the C-terminal KA-1 domain recruits U6 snRNA by interacting with the internal stem-loop (ISL). SAM binding to the N-terminal MTD catalytic pocket triggers a structural rearrangement of U6 snRNA that positions the target adenine at the catalytic site, followed by an additional adjustment into a productive conformation bringing the target adenosine closer to SAM for efficient m6A modification.\",\n      \"method\": \"Cryo-EM structure determination of METTL16-U6 snRNA complex\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure providing atomic-level mechanistic insight into substrate recognition and catalytic mechanism; single study\",\n      \"pmids\": [\"40841561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"UFL1 loss decreases METTL16 UFMylation, which reduces METTL16 ubiquitination and increases its protein stability. Stabilized METTL16 installs m6A on EEF1A1 mRNA, activating the IGF2BP1 axis to increase EEF1A1 protein levels and enhance resistance to enzalutamide-induced apoptosis in prostate cancer.\",\n      \"method\": \"Co-immunoprecipitation, MeRIP for EEF1A1 m6A, RIP for IGF2BP1, overexpression/knockdown experiments, in vitro and in vivo xenograft models\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — Co-IP and MeRIP identifying UFMylation as PTM controlling METTL16 stability; single lab with multiple assays\",\n      \"pmids\": [\"41608626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Aminothiazolone compounds were identified as first-in-class small-molecule inhibitors of METTL16 that disrupt METTL16-RNA protein-RNA interaction at single-digit micromolar potency, validated by fluorescence-polarization screening and structural optimization.\",\n      \"method\": \"Fluorescence-polarization (FP)-based screening, medicinal chemistry optimization, cellular m6A modulation assays\",\n      \"journal\": \"JACS Au\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — FP binding assay plus cellular validation; single lab; establishes RNA-binding surface as druggable\",\n      \"pmids\": [\"38665670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"METTL16 controls KSHV lytic replication by promoting m6A modification and splicing/maturation of MAT2A transcript, thereby maintaining intracellular SAM levels and redox homeostasis (glutathione levels); SAM treatment is sufficient to inhibit KSHV lytic replication and reverse the effect of METTL16 knockdown.\",\n      \"method\": \"siRNA knockdown, SAM supplementation, MAT2A inhibitor treatment, ROS and glutathione measurements, KSHV lytic gene expression analysis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — epistasis established by SAM rescue of METTL16 knockdown phenotype; single lab with multiple complementary approaches\",\n      \"pmids\": [\"37673880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"METTL16 collaborates with IGF2BP2 to modulate SENP3 mRNA stability in an m6A-dependent manner; SENP3 in turn impedes proteasome-mediated ubiquitination/degradation of Lactotransferrin (LTF) via de-SUMOylation, elevating LTF to chelate free iron and reduce labile iron pool, conferring ferroptosis resistance in HCC.\",\n      \"method\": \"MeRIP-qPCR, RIP-qPCR, Co-IP, mass spectrometry, luciferase assay, hepatocyte-specific Mettl16 KO and OE mice, HCC organoids, xenografts\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and MeRIP plus in vivo KO/OE models and organoids establishing the mechanistic axis; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"39218945\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"METTL16 is a SAM-dependent N6-methyladenosine (m6A) RNA methyltransferase with a Rossmann-fold catalytic domain and a C-terminal vertebrate-conserved/KA-1 domain that recruits U6 snRNA via its internal stem-loop; upon SAM binding, U6 snRNA undergoes conformational rearrangement for productive m6A modification at A43 (critical for 5' splice site recognition); in the nucleus METTL16 also methylates structured hairpins in the MAT2A 3' UTR, and its catalytic efficiency sets the intracellular SAM setpoint by modulating MAT2A intron retention—under SAM-limiting conditions, slow enzymatic turnover increases METTL16 occupancy on MAT2A hp1, promoting splicing and SAM synthetase induction; in the cytoplasm, METTL16 promotes translation initiation in an m6A-independent manner by interacting with eIF3a/b and sequestering the translational repressor eIF4E2; additionally, METTL16 interacts with MRE11 through RNA to inhibit DNA end resection until ATM-mediated phosphorylation at Ser329/conformational change releases this inhibition, linking METTL16 to homologous recombination control; post-translational modifications (lactylation at K229 by copper/metabolic stress, UFMylation by UFL1, phosphorylation at Ser329 by CDK13) tune its activity and stability; collectively, these m6A-dependent and independent functions of METTL16 govern SAM homeostasis, splicing, translation, genome integrity, and cell fate decisions including spermatogenesis, erythropoiesis, and embryonic development.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"METTL16 is a SAM-dependent N6-methyladenosine (m6A) RNA methyltransferase that uses a Class I Rossmann-fold catalytic domain to recognize structured RNA substrates in which the target adenosine is presented in a bulge or hairpin [#0, #3, #5]. It methylates A43 within the ACAGAGA box of U6 spliceosomal snRNA—a position that base-pairs with 5' splice sites—linking the enzyme directly to splice site recognition [#1, #18]. A C-terminal vertebrate-conserved KA-1-like domain recruits U6 snRNA through its internal stem-loop, and SAM binding to the catalytic pocket triggers a conformational rearrangement that repositions the target adenosine for productive catalysis [#6, #27]. Its kinetic mechanism is ordered-sequential, with RNA binding preceding SAM, and slow catalytic turnover underlies a regulatory function: METTL16 methylates conserved hairpins in the MAT2A 3' UTR, and under SAM-limiting conditions increased occupancy on hp1 promotes splicing of a retained intron to induce the SAM synthetase MAT2A, making METTL16 catalytic efficiency the determinant of the intracellular SAM setpoint [#0, #16, #26]. Its mRNA m6A marks are decoded by reader proteins (YTHDC1, YTHDF2, IGF2BP1, YTHDC2) to control transcript stability and fate across diverse settings including metabolic reprogramming, hematopoiesis, and cell cycle progression [#2, #14, #21, #24]. Beyond catalysis, METTL16 acts through m6A-independent routes: in the cytosol it engages eIF3a/eIF3b and rRNA to promote translation-initiation complex assembly and sequesters the repressor eIF4E2 to favor cap recognition, while in the nucleus it binds MRE11 via RNA to restrain DNA end resection until ATM-dependent phosphorylation at Ser329 relieves this inhibition, linking the protein to homologous recombination and genome integrity [#9, #11, #10]. METTL16 is essential in vivo, with loss causing peri-implantation embryonic lethality and defects in spermatogenesis, meiosis, and erythropoiesis [#3, #20, #22, #15]. Its activity and stability are tuned by post-translational modifications including lactylation at K229, CDK13-mediated Ser329 phosphorylation, and UFL1-dependent UFMylation [#13, #24, #28].\"\n  ,\n  \"teleology\": [\n    {\n      \"year\": 2017,\n      \"claim\": \"Established METTL16's core identity as the m6A writer for U6 snRNA and for the MAT2A 3' UTR, defining its dual role in splicing and SAM homeostasis.\",\n      \"evidence\": \"In vitro methylation with recombinant enzyme, knockdown, splicing/intron-retention assays, methionine starvation; CRAC mapping and co-IP of U6 biogenesis factors\",\n      \"pmids\": [\"28525753\", \"29051200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the structural basis of substrate selection\", \"Reader proteins decoding MAT2A m6A not yet defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified YTHDC1 as the reader linking METTL16-deposited m6A on MAT2A to SAM-responsive regulation, connecting the writer to a downstream effector.\",\n      \"evidence\": \"In vitro methylation, siRNA of METTL16 and YTHDC1, mutagenesis of target sites, mRNA stability assays\",\n      \"pmids\": [\"29262316\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of stability versus splicing regulation not fully partitioned\", \"Redundancy among multiple target adenosines limits site-resolution dissection\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Solved crystal structures revealing how the methyltransferase domain reads structured RNA with the target adenosine in a bulge, and demonstrated an in vivo requirement via embryonic lethality of knockout mice.\",\n      \"evidence\": \"X-ray crystallography of apo, SAH-bound, and MAT2A-RNA-bound forms; SEC and gel-shift; Mettl16 knockout mouse embryos with RNA-seq\",\n      \"pmids\": [\"30197299\", \"30197297\", \"29593291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The C-terminal VCR/KA-1 contribution to U6 recognition was not captured\", \"Oligomeric state in functional context partially unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined how the vertebrate-conserved KA-1-like domain recruits U6 snRNA and remodels the A43 region for productive catalysis, explaining substrate-specific activation.\",\n      \"evidence\": \"Structural analysis, RNA-binding assays, MTD-KA1 chimera methylation assays, mutagenesis of the VCR basic region\",\n      \"pmids\": [\"32266935\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic detail of the SAM-triggered rearrangement awaited later cryo-EM\", \"Generalization of VCR function to other substrates unaddressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed METTL16 as substantially cytoplasmic and cell-cycle-regulated in its nuclear distribution, foreshadowing functions beyond nuclear m6A writing.\",\n      \"evidence\": \"Biochemical fractionation, endogenous vs FLAG-tagged IP; live imaging across cell cycle with co-IP of LBR, Lap2alpha, DDB2, and nucleolar proteins\",\n      \"pmids\": [\"31940410\", \"34357041\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of cytoplasmic pool not established at this stage\", \"Co-IP partners (LBR, Lap2alpha, DDB2) lack reciprocal/functional validation\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Uncovered m6A-independent cytoplasmic functions: METTL16 promotes translation initiation via eIF3a/eIF3b and rRNA binding and by sequestering the repressor eIF4E2 to favor cap recognition.\",\n      \"evidence\": \"Reciprocal Co-IP of eIF3a/b and eIF4E2, ribosome/polysome profiling, m6A-seq, methyltransferase-dead complementation, cap-binding assays\",\n      \"pmids\": [\"35145225\", \"36840945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How nuclear writer and cytoplasmic translation roles are partitioned mechanistically is unclear\", \"Direct structural basis of eIF interactions not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Linked METTL16 to genome integrity through an RNA-mediated, catalysis-independent interaction with MRE11 that gates DNA end resection and is released by ATM phosphorylation at Ser329.\",\n      \"evidence\": \"Co-IP, in vitro exonuclease assays with recombinant proteins, ATM kinase assays, phosphomimetic/phospho-dead mutants\",\n      \"pmids\": [\"36138131\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the bridging RNA species not defined\", \"Structural model of the METTL16-RNA-MRE11 complex absent\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated m6A-dependent control of metabolism and stem cell fate, with METTL16 driving BCAA reprogramming in AML and safeguarding genome integrity during erythropoiesis.\",\n      \"evidence\": \"CRISPR screens, conditional/genetic depletion in AML mouse models and erythroid cells, m6A-seq, RIP-seq, metabolic profiling, pairwise CRISPRi screen\",\n      \"pmids\": [\"36608679\", \"36307435\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect effects on individual target transcripts not fully separated\", \"Role of MTR4-exosome in shaping the substrate pool incompletely defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established METTL16's kinetic mechanism as ordered-sequential (RNA before SAM) with slow turnover, providing the biochemical basis for its SAM-sensing regulatory behavior.\",\n      \"evidence\": \"Kd measurements, preincubation/isotope partitioning, steady-state and single-turnover kinetics\",\n      \"pmids\": [\"36584291\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Connection of measured kinetics to cellular SAM setpoint awaited later work\", \"MALAT1 triple helix bound but not methylated, leaving its role unexplained\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed PTM control and reader-dependent target regulation, with lactylation at K229 (inhibited by SIRT2) enhancing FDX1 m6A and YTHDF2-mediated MCP1 degradation extending the m6A output to inflammation and cuproptosis.\",\n      \"evidence\": \"MS identification of lactylation, SIRT2 manipulation, MeRIP, RIP for YTHDF2/readers, stability and functional assays\",\n      \"pmids\": [\"37863889\", \"36795489\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry and generality of K229 lactylation not established\", \"Whether PTMs alter catalytic versus non-catalytic functions unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined developmental and germline roles via conditional knockouts, showing METTL16 controls splicing and translation of meiotic genes, MSCI, spermatogonial differentiation, and HSPC cell cycle.\",\n      \"evidence\": \"Germline/spermatocyte and zebrafish conditional knockouts, m6A-seq, RNA-seq, ribosome profiling, co-IP with splicing factors and MDC1/SCML2, activity-mutant rescue, RIP for IGF2BP1\",\n      \"pmids\": [\"39030605\", \"39607422\", \"38605226\", \"39614650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Tissue-specific substrate repertoires only partially mapped\", \"Mechanism coupling splicing-factor interactions to specific exon choices not fully defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified additional PTM writers and cofactors—CDK13 phosphorylation at Ser329 boosting activity, UFL1-dependent UFMylation controlling stability, and SSB acting as an RNA-binding cofactor and substrate.\",\n      \"evidence\": \"In vitro kinase assays, phosphomimetic mutants, MeRIP, Co-IP, RIP for readers, knockdown/overexpression in cancer models\",\n      \"pmids\": [\"41680470\", \"41608626\", \"40580478\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interplay among Ser329 phosphorylation, UFMylation, and lactylation not integrated\", \"Endogenous cofactor stoichiometry of SSB unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrated that METTL16 catalytic efficiency itself sets the intracellular SAM setpoint and resolved the cryo-EM mechanism of U6 recognition and SAM-triggered substrate repositioning.\",\n      \"evidence\": \"Degron depletion/complementation with hyperactive and dead mutants, SAM and methylation measurements, MTAP deletion; cryo-EM of METTL16-U6 snRNA complex\",\n      \"pmids\": [\"40644296\", \"40841561\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether catalytic-efficiency tuning is exploited therapeutically remains untested\", \"Structural basis for mRNA hairpin recognition versus U6 not directly compared\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How METTL16 partitions between its m6A-writer, translation-promoting, and DNA-repair functions, and how its many PTMs are coordinated to select among these activities, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified model integrating catalytic and non-catalytic roles\", \"Bridging RNAs in non-catalytic complexes (e.g., MRE11) unidentified\", \"Cell-type-specific determinants of substrate choice undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 1, 2, 4, 16, 27]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 5, 9, 10, 16]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 17, 27]},\n      {\"term_id\": \"GO:0045182\", \"supporting_discovery_ids\": [9, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 8, 9]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7, 9, 11]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 2, 27]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 12, 26]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [9, 11, 19]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [10, 15]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 20, 21, 22]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"MRE11\", \"eIF3a\", \"eIF3b\", \"eIF4E2\", \"YTHDC1\", \"LARP7\", \"MEPCE\", \"SSB\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}